Special Issue "Radiotherapy and Cancer"
A special issue of Healthcare (ISSN 2227-9032).
Deadline for manuscript submissions: closed (30 June 2019).
Interests: radiobiological models, oropharyngeal cancer trials, mucositis
Radiotherapy for cancer is rapidly evolving: the use of protons with the aim of sparing acute and late radiation toxicity and reducing second malignancies is becoming more widespread; interest in the potential use of other ions is increasing; stereotactic ablative body radiotherapy is being widely used as an alternative to surgery or to delay the initiation of palliative systemic chemotherapy; combinations of precision surgery and lower dose radiotherapy are being examined in randomized trials; immunotherapy is being tested in combination with radiotherapy; there is a renewed emphasis on both contour peer review and more detailed guidelines for clinical target volume definition. The purpose of this Special Issue is to examine these and other developments in radiotherapy.
Dr. Andrew Hartley
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Radiation Toxicity
- Heavy Ions
- SABR (stereotactic ablative body radiotherapy)
- Radiotherapy dose de-escalation
- Peer review